NUVB Competitors & Alternatives
Compare Nuvation Bio Inc with similar stocks in the same industry
Biotechnology
NUVB
Main Stock$6.49
Tradestie Score
64
Market Cap
$1.27B
Revenue Growth
26.0%
Analyst Upside
+90.0%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$25.25
|
$2.18B | - | 60 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.62
|
$2.08B | - | 60 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.08
|
$2.02B | 49.7 | 53 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$15.73
|
$2.01B | - | 57 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$37.92
|
$1.97B | - | 61 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.92
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$96.29
|
$1.92B | - | 54 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$75.97
|
$1.90B | 444.1 | 59 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$40.09
|
$1.84B | - | 56 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.12
|
$1.81B | - | 64 | Compare |
More NUVB Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry